packageNusinersen

nusinersen

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nusinersen is an antisense oligonucleotide medicine used to treat spinal muscular atrophy. It is authorised in the European Union and is an approved drug, used for this rare muscle-wasting condition.

Summary written by glm-5.3-flash from Wikidata Q25105466 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:nusinersen
ATC codes:M09AX07
DrugBank:DB13161
Wikidata:Q25105466

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown